logo

Abiomed Inc. (ABMD)



Trade ABMD now with
  Date
  Headline
6/16/2020 7:03:54 AM Abiomed Launches Cutting-edge Digital Education Platform Called CAMP PCI
6/15/2020 7:05:00 AM Abiomed Appoints Charles Simonton VP And Chief Medical Officer
6/5/2020 7:08:22 AM Abiomed Says FDA Approves First-in-Human Trial Of Impella ECP Heart Pump
6/1/2020 7:04:52 AM Abiomed: FDA Issues Emergency Use Authorization For Impella RP As Therapy For COVID-19 Patients With Right Heart Failure
5/19/2020 9:34:42 AM PROTECT III Study Shows Placing Impella Prior To High-Risk PCI Associated With Lower Mortality Compared To Bailout PCI
4/30/2020 7:07:10 AM Abiomed Q4 GAAP Net Income $31.8 Mln Or $0.70/shr Vs. $74.0 Mln Or $1.60/shr Last Year
3/25/2020 7:09:32 AM Abiomed Says Continuing To Manufacture And Support Patients; Maintains Appropriate Levels Of Inventory
1/13/2020 7:26:38 AM Abiomed Preliminary Q3 Revenue $221.6 Mln, Up 10% From Last Year
10/31/2019 7:29:38 AM Abiomed Q2 Net Income $13.1 Mln Vs. $50.1 Mln Last Year
9/25/2019 7:08:47 AM Abiomed Gets FDA PMA Approval For Impella 5.5 With SmartAssist For Efficacy In Therapy Of Cardiogenic Shock For 14 Days
1/31/2019 7:15:28 AM Abiomed Q3 GAAP Net Income $44.9 Mln Or $0.97/Shr Vs $13.4 Mln Or $0.29/Shr Last Year
1/7/2019 7:10:20 AM Abiomed Reports Q3 Preliminary Revenue Of $200.6 Mln, Increase Of 30%
11/1/2018 7:26:27 AM Abiomed Q2 GAAP Net Income $50.1 Mln Or $1.09/Shr Vs $24.5 Mln Or $0.54/Shr Prior Year
10/9/2018 12:05:15 PM Orchestra BioMed Adds Eric Rose, Jason Aryeh And Gary Pruden To Strategic Advisory Board